vs

Side-by-side financial comparison of MFA FINANCIAL, INC. (MFA) and PETMED EXPRESS INC (PETS). Click either name above to swap in a different company.

MFA FINANCIAL, INC. is the larger business by last-quarter revenue ($55.5M vs $40.7M, roughly 1.4× PETMED EXPRESS INC). On growth, MFA FINANCIAL, INC. posted the faster year-over-year revenue change (9.2% vs -23.3%). Over the past eight quarters, MFA FINANCIAL, INC.'s revenue compounded faster (7.7% CAGR vs -20.9%).

MFA Financial, Inc. is a U.S.-headquartered real estate investment trust (REIT) specializing in investing in and managing residential and commercial mortgage-backed securities, mortgage loans, and other real estate-related financial assets. It caters primarily to institutional and individual investors across the U.S., focusing on delivering stable risk-adjusted returns via rigorous asset screening and risk management frameworks.

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

MFA vs PETS — Head-to-Head

Bigger by revenue
MFA
MFA
1.4× larger
MFA
$55.5M
$40.7M
PETS
Growing faster (revenue YoY)
MFA
MFA
+32.5% gap
MFA
9.2%
-23.3%
PETS
Faster 2-yr revenue CAGR
MFA
MFA
Annualised
MFA
7.7%
-20.9%
PETS

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
MFA
MFA
PETS
PETS
Revenue
$55.5M
$40.7M
Net Profit
$-10.6M
Gross Margin
23.3%
Operating Margin
97.9%
-25.7%
Net Margin
-26.0%
Revenue YoY
9.2%
-23.3%
Net Profit YoY
-1392.6%
EPS (diluted)
$0.43
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MFA
MFA
PETS
PETS
Q4 25
$55.5M
$40.7M
Q3 25
$56.8M
$44.4M
Q2 25
$61.3M
$51.2M
Q1 25
$57.5M
$50.8M
Q4 24
$50.8M
$52.0M
Q3 24
$50.6M
$58.0M
Q2 24
$53.5M
$66.2M
Q1 24
$47.8M
$65.1M
Net Profit
MFA
MFA
PETS
PETS
Q4 25
$-10.6M
Q3 25
$48.1M
$-8.5M
Q2 25
$33.2M
$-34.2M
Q1 25
$41.2M
$-11.6M
Q4 24
$-707.0K
Q3 24
$48.2M
$2.3M
Q2 24
$41.9M
$3.8M
Q1 24
$23.2M
$-5.0M
Gross Margin
MFA
MFA
PETS
PETS
Q4 25
23.3%
Q3 25
28.0%
Q2 25
28.1%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
32.3%
Q2 24
28.8%
Q1 24
29.3%
Operating Margin
MFA
MFA
PETS
PETS
Q4 25
97.9%
-25.7%
Q3 25
84.5%
-18.9%
Q2 25
54.5%
-66.7%
Q1 25
70.0%
-11.9%
Q4 24
6.8%
-0.9%
Q3 24
98.2%
1.0%
Q2 24
79.1%
6.6%
Q1 24
50.7%
-5.9%
Net Margin
MFA
MFA
PETS
PETS
Q4 25
-26.0%
Q3 25
84.7%
-19.2%
Q2 25
54.2%
-66.7%
Q1 25
71.6%
-22.9%
Q4 24
-1.4%
Q3 24
95.2%
4.0%
Q2 24
78.4%
5.7%
Q1 24
48.5%
-7.7%
EPS (diluted)
MFA
MFA
PETS
PETS
Q4 25
$0.43
$-0.50
Q3 25
$0.35
$-0.41
Q2 25
$0.21
$-1.65
Q1 25
$0.31
$-0.56
Q4 24
$-0.01
$-0.03
Q3 24
$0.37
$0.11
Q2 24
$0.32
$0.18
Q1 24
$0.14
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MFA
MFA
PETS
PETS
Cash + ST InvestmentsLiquidity on hand
$213.2M
$26.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.8B
$32.8M
Total Assets
$13.0B
$88.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MFA
MFA
PETS
PETS
Q4 25
$213.2M
$26.9M
Q3 25
$305.2M
$36.1M
Q2 25
$275.7M
$41.1M
Q1 25
$253.7M
$54.7M
Q4 24
$338.9M
$50.1M
Q3 24
$305.6M
$52.0M
Q2 24
$289.4M
$46.0M
Q1 24
$306.3M
$55.3M
Stockholders' Equity
MFA
MFA
PETS
PETS
Q4 25
$1.8B
$32.8M
Q3 25
$1.8B
$43.1M
Q2 25
$1.8B
$51.5M
Q1 25
$1.8B
$85.1M
Q4 24
$1.8B
$96.2M
Q3 24
$1.9B
$96.4M
Q2 24
$1.9B
$93.5M
Q1 24
$1.9B
$96.7M
Total Assets
MFA
MFA
PETS
PETS
Q4 25
$13.0B
$88.0M
Q3 25
$12.1B
$100.3M
Q2 25
$11.7B
$109.8M
Q1 25
$11.5B
$148.7M
Q4 24
$11.4B
$144.8M
Q3 24
$11.2B
$146.0M
Q2 24
$11.1B
$152.7M
Q1 24
$10.9B
$169.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MFA
MFA
PETS
PETS
Operating Cash FlowLast quarter
$76.2M
$-9.2M
Free Cash FlowOCF − Capex
$-9.2M
FCF MarginFCF / Revenue
-22.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-23.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MFA
MFA
PETS
PETS
Q4 25
$76.2M
$-9.2M
Q3 25
$14.7M
$-2.2M
Q2 25
$38.5M
$-12.3M
Q1 25
$-14.6M
$7.0M
Q4 24
$200.1M
$-1.2M
Q3 24
$-11.3M
$7.4M
Q2 24
$46.5M
$-8.5M
Q1 24
$53.5M
$7.1M
Free Cash Flow
MFA
MFA
PETS
PETS
Q4 25
$-9.2M
Q3 25
$-4.8M
Q2 25
$-13.6M
Q1 25
$4.6M
Q4 24
$-1.9M
Q3 24
$6.1M
Q2 24
$-9.2M
Q1 24
$5.9M
FCF Margin
MFA
MFA
PETS
PETS
Q4 25
-22.7%
Q3 25
-10.8%
Q2 25
-26.5%
Q1 25
9.1%
Q4 24
-3.7%
Q3 24
10.6%
Q2 24
-13.9%
Q1 24
9.0%
Capex Intensity
MFA
MFA
PETS
PETS
Q4 25
0.1%
Q3 25
5.9%
Q2 25
2.5%
Q1 25
4.7%
Q4 24
1.5%
Q3 24
2.2%
Q2 24
1.0%
Q1 24
1.9%
Cash Conversion
MFA
MFA
PETS
PETS
Q4 25
Q3 25
0.31×
Q2 25
1.16×
Q1 25
-0.35×
Q4 24
Q3 24
-0.23×
3.18×
Q2 24
1.11×
-2.27×
Q1 24
2.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MFA
MFA

Segment breakdown not available.

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

Related Comparisons